Targeted therapy with kinase inhibitors in aggressive endocrine tumors.

Targeted therapy with kinase inhibitors in aggressive endocrine tumors.

Item
http://www.wikidata.org/entity/Q38107011
Everolimus-based combination for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): biological rationale and critical review of published data.Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review.Efficacy and Safety of Everolimus in Extrapancreatic Neuroendocrine Tumor: A Comprehensive Review of Literature.Successful recovery from a subclavicular ulcer caused by lenvatinib for thyroid cancer: a case report.Kinase-targeted cancer therapies: progress, challenges and future directions.Complete disappearance of liver metastases in a patient with iodine-refractory differentiated thyroid cancer subjected to sorafenib re-challenge.Sorafenib in the treatment of thyroid cancer.Molecular testing in the diagnosis of differentiated thyroid carcinomas
P2860

Targeted therapy with kinase inhibitors in aggressive endocrine tumors.

Item
http://www.wikidata.org/entity/Q38107011
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeted therapy with kinase inhibitors in aggressive endocrine tumors.
@en
type
label
Targeted therapy with kinase inhibitors in aggressive endocrine tumors.
@en
prefLabel
Targeted therapy with kinase inhibitors in aggressive endocrine tumors.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Targeted therapy with kinase inhibitors in aggressive endocrine tumors.
@en
P2093
P2860
P304
P31
P356
10.1517/14656566.2013.796931
P407
P433
P478
P50
P577
P5875
P698